genciana

Gentian (Gentiana lutea L.)

1. Identity: Botanical Classification, Names, and Natural Source

Gentiana lutea, the great yellow gentian, is a species of gentian native to the mountains of central and southern Europe, including the Alps, the Carpathians, the Pyrenees, the Apennines, and the mountains of the Balkan Peninsula. It is the type species of the genus Gentiana and is a herbaceous perennial plant, growing to 1–2 m (3.3–6.6 ft) tall, with broad lanceolate to elliptic glabrous leaves 10–30 cm long and 4–15 cm broad, borne in opposite pairs.

It belongs to the family Gentianaceae, and the medicinal part used is the radix (root). Its primary chemical constituent classes include glycosides, flavonoids, alkaloids, iridoids, xanthones, and phenolic acids.

The genus name has a specific historical origin. The scientific name Gentiana originates from King Gentius of Illyria in the second century BCE, who, according to tradition, was the first to recognize the medicinal properties of this plant and used its root in 167 BCE. Dioscorides wrote that Gentiana lutea was introduced into herbal medicine by King Gentius of Illyria, thus giving its name gentian.

Common names include Yellow Gentian, Bitter Root, Bitterwort, Felwort, and Gall Weed. There are over 400 different species of the Gentianaceae family, and at least several species of the genus Gentiana are used in herbal medicine, including Gentiana lutea, Gentiana manshurica Kitag, Gentiana scabra Bunge, Gentiana triflora pall, and Gentiana rigescens Franch. In the European pharmacopoeial and regulatory context, the drug is known under the Latin designation Gentianae radix, referring specifically to the dried underground organs (roots and rhizome) of Gentiana lutea L.

To date, G. lutea is an imperiled species in most European countries due to the uncontrolled harvesting of roots to extract bitter glucosides; for this reason, it is under protection. Gentian roots are collected and dried in central and southern Europe, with supply formerly coming substantially from Germany, though it is also imported from Switzerland, France, and Spain, and French gentian is considered of special excellence.

Common Dosage Forms and Preparations

Recognised preparations in the European Union monograph on Gentianae radix include: (a) comminuted herbal substance; (b) dry extract (4.5–5.5:1) ethanol 53% v/v; (c) tincture (1:5) ethanol 70% v/v; and (d) liquid extract (1:1) ethanol 45% v/v.

• Herbal tea (infusion or decoction): Combine half a teaspoon (1 gram) of dried gentian root with 150 millilitres of boiling water and allow 5 to 10 minutes to steep.
• Tincture: traditionally used as a liquid alcoholic preparation.
• Dry extract capsules/tablets: concentrated solid extracts used in modern supplement and pharmaceutical products.
• Aperitifs and digestive bitters: Gentian forms a key botanical ingredient in many European liqueurs including Aperol and Campari. Even today, it remains a component of alcoholic aperitifs, which are served before meals to stimulate appetite, as well as digestifs, which are served after meals to aid digestion.
• Combination products: Gentian root is used in specific combination products such as one containing gentian root, elderflower, verbena, cowslip flower, and sorrel (Sinupret/SinuComp).

The main active compounds in gentian root are iridoids, secoiridoids, xanthones, and flavonoids. The amounts of these compounds in the plant depend on the type of Gentiana plant, time and year of harvest, and drying process; thus, not every preparation of gentian root may offer the same benefits.

2. Traditional and Historical Use

Ancient Mediterranean Traditions

Gentian has a long and esteemed history of traditional use, primarily as a digestive aid and to strengthen the digestive system. The ancient Greeks, Romans, Egyptians, and Arab physicians all used gentian root as a herbal medicine, and it was especially indicated for health issues where a weakened digestive system was involved.

Romans actively used yellow gentian roots as a medicinal plant, specifically as an herbal bittering agent for gastrointestinal complaints. In the herbal books of the Middle Ages, yellow gentian roots were considered a universal remedy. In large part because plants containing bitter substances were considered particularly effective, and yellow gentian was the most bitter of all.

During the Middle Ages, gentian was commonly employed as an antidote to poison. Tragus, in 1552, mentions it as a means of dilating wounds.

Medieval European Herbalism

Hildegard von Bingen described the medicinal use of gentian: "who has fever in the stomach, often drinks powdered gentian in warm wine and his stomach is cleansed of fever."

Before the introduction of hops, gentian, with many other bitter herbs, was used occasionally in brewing. The rootstocks of some species have been used since the Middle Ages for the production of schnapps, as medicines, and to balance the appetite.

Iranian and Middle Eastern Traditional Medicine

Based on the studies of Iranian traditional medicine texts, there are some promising bioactivities for this genus. In traditional medicine texts, Gentiana's different exclusive forms of preparations are described as effective for treatment of some disorders such as menstrual over-bleeding, conjunctivitis, vitiligo, animal venom poisoning, injuries, infected wounds, pain and swelling of liver, spleen, stomach, and sprains of muscles.

Ayurvedic and South Asian Traditions

One of the most ancient systems of healing is the East Indian system of medicine, called Ayurveda. In this system, a number of gentians have been reported as being used, probably for at least two thousand years, including Gentiana decumbens Linn. f., which is used as a stomach remedy, and G. kurroo Royle (Indian gentian), a well-known tonic, stomach, and urinary-tract medicine and fever remedy.

Traditional Chinese Medicine

Herbs from the Gentianaceae family were used centuries ago as a part of traditional medicine in China and Tibet. The related western herb Gentiana lutea is used in traditional Chinese contexts to increase secretion of gastric juices and saliva, and to treat cases of loss of appetite, abdominal fullness and distension, and as a general tonic.

Spanish Folk Medicine

Gentiana lutea L. is well known for its long history of use as an herbal medicine for its antiseptic and anti-inflammatory characteristics. The dried underground parts of yellow gentian (roots and rhizome) were cooked together with walnut leaves in water and the remaining liquid was used to clean wounds in Cuevas del Sil (León, Spain).

Regulatory and Pharmacopoeial Traditional Recognition

The traditional use of Gentiana lutea, radix is sufficiently documented. A monograph for gentian root was established by the German Kommission E in 1985, which was revised in 1990. According to the monograph of Commission E in Germany, an infusion of this bitter-tasting crushed medicinal herb helps to balance appetite and resolve mild digestive disorders, such as flatulence and bloating. The European Scientific Cooperative on Phytotherapy (ESCOP) has a similar view of the applications, and the Committee on Herbal Medicinal Products (HMPC) has classified the gentian root as a traditional herbal medicinal.

Gentiana lutea and Gentiana cruciata are particularly valued for their ability to treat loss of appetite, gastrointestinal disorders, liver diseases, and promote wound healing. Due to their valuable properties, they have also been recognized in the European Pharmacopoeia and European Medicines Agency (EMA) guidelines.

3. Key Constituents and Active Compounds

Secoiridoid Glycosides (Primary Bitter Principles)

The bitter principles of gentian root are secoiridoid glycosides amarogentin and gentiopicrin. These compounds are among the most bitter natural substances known. Amarogentin, in particular, is widely cited as one of the bitterest compounds found in nature. The extracts of members of the Gentianaceae family have long been used as bitter stomachics because they contain bitter secoiridoid glycosides, including amarogentin, amaroswerin, swertiamarin, sweroside, and gentiopicroside, all of which enhance gastrointestinal motility and the secretion of digestive juices. Among them, amarogentin is known as the bitterest natural compound, and the root extract of Gentiana lutea is registered as a bitter food additive in the List of Existing Food Additives in Japan.

Other secoiridoid constituents identified include sweroside, swertiamarin, loganic acid (an iridoid), and gentiside. The most represented groups of secondary metabolites in G. lutea roots include secoiridoid-glycosides (gentiopicroside, gentiopicrin, swertiamarin, sweroside, and amarogentin), iridoids (loganic acid), xanthones (gentisin and isogentisin), and xanthone-glycosides (gentioside).

Xanthones

The bioactive compounds responsible for the antioxidant properties of Gentiana species predominantly include phenolic compounds such as ferulic acid, ellagic acid, and 4-hydroxybenzoic acid; iridoids; flavonoids such as luteolin, apigenin, and kaempferol; xanthones such as gentisin and isogentisin; and other compounds like gentiascabraside A and gentiatibetin. Xanthones, which occur predominantly in the root and aerial parts, contribute to the antioxidant and potentially neuroprotective profile of the plant.

Flavonoids

Secoiridoid and iridoid glycosides such as gentiopicroside, xanthones, monoterpene alkaloid, polyphenol, and flavones are the constituents that have been shown to have pharmacological activities in different gentian species. Among flavonoids, isovitexin has attracted particular attention for cardiovascular effects.

Alkaloids

Gentianine is a monoterpene alkaloid widely distributed in several plant species of the Gentianaceae family. It is a crystalline alkaloid and an active metabolite of swertiamarin, which has been reported to have diverse pharmacological activities.

Carbohydrates and Primary Metabolites

HPLC-DAD and NMR metabolomics analyses have confirmed that wild Gentiana lutea root has a rich composition in bioactive compounds such as secoiridoids, iridoids, and xanthones, along with primary metabolites like sugars, organic acids and amino acids, and fatty acids. Among the carbohydrates present are fructose, saccharose, gentiobiose (a disaccharide), and gentianose (a trisaccharide).

4. Mechanisms of Action

Bitter Taste Receptor Activation and Cephalic-Phase Response

The secoiridoid bitter compounds amarogentin and gentiopicroside stimulate TAS2Rs (bitter taste receptors) in the oropharynx and gastrointestinal tract. This triggers vagally mediated reflex activation of digestive secretions and motility.

Gentian root contains bitter secoiridoid glycosides such as gentiopicroside and amarogentin, among the most bitter natural substances known. These compounds stimulate bitter taste receptors in the oropharynx and gastrointestinal tract, activating the vagus nerve and triggering a cephalic phase digestive response. This includes gastric acid secretion, improved motility, and modulation of gut hormone release.

The mechanism underlying the traditional use of bitters is thought to be cephalic phase responses elicited through bitter receptors found in the taste buds of the tongue and throughout the GI tract. Cephalic responses, such as influencing digestive juice production and blood flow to the gut, prepare the GI tract for food processing.

Anti-inflammatory Mechanisms

The hydroalcoholic extract of G. lutea has demonstrated significant dose-dependent anti-inflammatory activity in ex vivo LPS-stimulated mouse colon tissue, reducing the expression of pro-inflammatory cytokines (IL-6, TNF-α) and enhancing the expression of the anti-inflammatory cytokine IL-10.

Across experimental models, gentian extracts and isolated compounds have demonstrated antioxidant, anti-inflammatory, anti-obesity, anti-atherosclerotic, antimicrobial, neurotrophic, gastroprotective, hepatoprotective, cytoprotective, and dermatological activities, mediated through mechanisms including modulation of oxidative stress, inhibition of inflammatory cytokines and adhesion molecules, regulation of lipid and glucose metabolism, activation of AMPK and eNOS signalling, inhibition of smooth muscle cell proliferation and migration, bitter taste receptor activation, and effects on neuronal survival and neurotransmission.

Antioxidant Mechanisms

G. lutea extracts have shown excellent antioxidant activity measured by DPPH scavenging assay and Trolox equivalent antioxidant capacity (TEAC) assays. Extracts derived from both the root and aerial parts of Gentiana lutea have been identified as effective radical scavengers. Similarly, an ethanol extract from Gentiana septemfida exhibited high capacity to neutralize free radicals.

Hepatoprotective Mechanisms

Gentiana lutea extracts have been shown to reduce lipid peroxidation, protein carbonylation, oxidative stress, and overall hepatotoxicity in rat models with ketoconazole-induced oxidative stress. Antioxidant phytochemicals including sweroside, swertiamarin, and gentiopicroside found in Swertia chirayita extract (a closely related genus) may be responsible for hepatoprotective action in HepG2 cells exposed to acetaminophen.

Cardiovascular and Anti-atherosclerotic Mechanisms

Research has shown that gentian herbs possess various pharmacological properties, such as anti-inflammatory, antioxidant, and vasodilatory effects, which play a key role in improving vascular health. The flavonoid constituent isovitexin has been specifically identified as relevant to cardiovascular actions, including the prevention of atherosclerosis and reduction in total cholesterol levels.

Neuroprotective Mechanisms

Bellidifolin (a xanthone from Gentiana species) reduced hypoxia-induced expression of phosphorylated p38 MAPK (p-p38 MAPK) and caspase-3, thereby reducing apoptosis in hypoxia-induced nerve injury. The alkaloid gentianine and several secoiridoids are also considered to contribute to observed CNS-related effects in animal models.

5. Scientific Evidence by Area of Use

5.1 Digestive Health, Dyspepsia, and Appetite

This is the area of use with the longest history of formal regulatory recognition and the most clinical data, though the quality of evidence remains limited.

The HMPC concluded that, on the basis of its long-standing use, gentian root preparations can be used for temporary loss of appetite and for mild stomach and gut complaints such as indigestion. These conclusions for mild stomach and gut complaints are based on their "traditional use," meaning that although there is insufficient evidence from clinical trials, the effectiveness of these herbal medicines is plausible and there is evidence that they have been used safely in this way for at least 30 years (including at least 15 years within the EU).

The considerable bitter taste of gentian provides a theoretical basis for its use in dyspepsia and flatulence, for which an increase in saliva and gastric acid secretion would be beneficial. Commission E and the European Scientific Cooperative on Phytotherapy (ESCOP) approve its use for this indication. In an open study, 205 patients with various dyspeptic symptoms (heartburn, vomiting, stomach pain, nausea, loss of appetite, constipation, flatulence) were treated with a dry hydro-ethanolic extract (5:1) of gentian root at a dose of 240 mg two or three times a day (mean daily dose of 576 mg of extract, equivalent to 2.9 g of dried root) for about 15 days. Symptom improvement was evident after 5 days in most cases and, at the end of the study, the average level of improvement was 68%. The efficacy of the preparation was rated by physicians as excellent (symptom elimination) in 31% of patients, good in 55%, moderate in 9%, and insufficient in 5% of cases.

Ethanol extracts of the roots and rhizomes of G. lutea have increased gastric secretions in rats and sheep (WHO 1999). In two uncontrolled clinical studies, stimulation of gastric secretions was increased and GI symptoms (e.g., abdominal pain, constipation, dyspepsia, heartburn) were reduced (WHO 1999).

A small human study confirmed that oral administration of a gentian root extract increases the secretion of gastric juice and the emptying of the gallbladder.

Evidence assessment: No well-designed clinical trials support the traditional use of gentian to stimulate appetite, improve digestion, or treat GI complaints. Evidence is largely mechanistic (bitter taste receptor activation), regulatory (traditional use recognition by Commission E, ESCOP, and EMA/HMPC), and from small or uncontrolled human studies. The pharmacological rationale is well-established, but rigorous randomized controlled trials specifically for Gentiana lutea alone are lacking.

5.2 Respiratory Health: Sinusitis (Combination Product — Sinupret)

The most robust clinical evidence for a preparation containing gentian root relates not to gentian alone, but to the proprietary combination product Sinupret (also known as BNO-101).

The herbal formula BNO-101 (containing Gentianae radix, Primulae flos, Rumicis herba, Sambuci flos, and Verbenae herba; ratio 1:3:3:3:3) has been widely employed as a "mucoactive" agent in Germany for 70 years for the symptoms of respiratory infections. This paper reviews the clinical evidence of BNO-101 in sinusitis.

The systematic search identified 22 studies with BNO-101. Out of these, 6 controlled trials on sinusitis were reassessed according to predefined criteria; 4 trials had almost identical designs and could be examined by meta-analysis. The database comprised approximately 900 patients, mostly young adult males. After 2 weeks of treatment, verum was significantly superior to placebo (2 RCTs, 159 vs. 160 patients, both add-on to antibacterial treatment). The benefit includes patients' assessment ("cured": verum = 61.1%, placebo = 34.5%), reduction of drain obstruction, headache, and radiological signs (all p < 0.05).

In a randomized, placebo-controlled double-blind clinical trial involving 160 patients with acute bacterial sinusitis, the efficacy of an additional treatment with the herbal combination Sinupret containing gentian root, cowslip flowers, sour dock herbs, elder flowers, and shop vervain wort herbs was assessed.

Evidence assessment: The Sinupret data comes from combination-product studies. No individual contribution of gentian root to the observed sinusitis effects can be definitively isolated. The studies are promising but cannot be attributed solely to Gentiana lutea.

5.3 Anti-inflammatory Activity

A hydroalcoholic extract of G. lutea roots demonstrated significant dose-dependent anti-inflammatory activity in ex vivo LPS-stimulated mouse colon tissue, reducing the expression of pro-inflammatory cytokines (IL-6, TNF-α) and enhancing the expression of the anti-inflammatory cytokine IL-10. This 2025 study used a preparation mimicking a traditional Italian gentian liqueur and provided ex vivo (not human clinical) data.

Evidence assessment: Anti-inflammatory activity is well-supported in preclinical (in vitro and animal) models. Current knowledge treats this as providing a detailed overview of the potential use of gentian for the treatment of various diseases, but these are mainly pre-clinical results that need further confirmation by clinical trials.

5.4 Antioxidant Properties

G. lutea extracts showed excellent antioxidant activity measured by DPPH scavenging assay and Trolox equivalent antioxidant capacity (TEAC) assays. An amount of 0.5% w/w G. lutea lyophilisate was able to inhibit lipid oxidation throughout storage.

Evidence assessment: Antioxidant activity is well-documented in laboratory settings. Human clinical evidence for antioxidant benefit is absent.

5.5 Hepatoprotective Effects

Traditional medicine texts indicate preparations effective for pain and swelling of the liver and spleen. Some activities that are the same in traditional and modern medicine include anti-inflammatory, hepatoprotective, and diuretic effects. Preclinical data, particularly regarding the secoiridoid gentiopicroside, support mechanisms including upregulation of hepatic bile acid synthesis enzymes and reduced oxidative hepatotoxicity in rodent models.

Evidence assessment: Evidence is preclinical (in vitro and rodent models). No human clinical trials on hepatoprotective effects of Gentiana lutea alone have been identified in peer-reviewed literature.

5.6 Cardiovascular and Anti-atherosclerotic Effects

Research has shown that gentian herbs possess various pharmacological properties, such as anti-inflammatory, antioxidant, and vasodilatory effects, which play a key role in improving vascular health. Studies suggest that Gentiana-based therapeutics represent potentially useful drugs for the management of vascular diseases.

In vitro studies (notably Kesavan et al., 2016, published in Nutrition, Metabolism and Cardiovascular Diseases) investigated the anti-atherosclerotic mechanisms of Gentiana lutea extracts, focusing on endothelial inflammation and smooth muscle cell migration — key processes in atherosclerosis development. The isovitexin flavonoid constituent has shown atherosclerosis-prevention activity in cell models.

Evidence assessment: Cardiovascular effects are supported by cell line and in vitro studies only. No human clinical trials have been conducted.

5.7 Anti-obesity Effects

Gentiana lutea has been studied for anti-obesity effects. Studies in a 3T3-L1 preadipocyte model and high-fat diet-induced mouse model have been reported in the peer-reviewed literature (PMC7288051), examining gentian's influence on lipid metabolism and adipogenesis.

Evidence assessment: Evidence is preclinical only (cell lines and animal models). No human data exist.

5.8 Antimicrobial Activity

Studies including Savikin et al. (2009, Z. Naturforsch. C J. Biosci.) have documented antimicrobial activity of Gentiana lutea L. extracts in laboratory assays. In traditional medicine texts, gentiana preparations were used for conjunctivitis, infected wounds, and animal venom poisoning.

Evidence assessment: In vitro evidence only. Not validated in human clinical trials.

5.9 Neuroprotective and Central Nervous System Effects

A methanolic extract of Gentiana lutea ssp. symphyandra roots has been investigated for its potential impacts on the central nervous system of mice. At doses of 250 and 500 mg/kg per i.p., the methanol extract of gentian roots induced a significant improvement in the swimming endurance test and showed weak analgesic activity, but no lethality in mice, implying remarkable activity on the central nervous system. However, there was no indication of sedation or muscular fatigue at the doses exercised. HPLC analysis found that three secoiridoid compounds — gentiopicroside, swertiamarin, and sweroside — were reported and may have been responsible for the CNS effects.

A separate study evaluated the effect of G. lutea root extract on anti-proliferative activity of pro-apoptotic agents in the human SH-SY5Y neuroblastoma cell line, with a focus on neuroprotection.

Evidence assessment: Neuroprotective evidence is preclinical (animal and cell line). No human data.

5.10 Dermatological Application

One mixed pre-clinical and human study investigated the effects of a Gentiana lutea extract (GIE) standardised to gentiopicroside (65%) on periocular skin parameters associated with dark circles. Another study claims that Gentiana lutea extract might be used to improve some skin disorders with an impaired epidermal barrier, very dry skin, and atopic eczema.

Evidence assessment: Very preliminary; primarily preclinical and one small mixed study. Not sufficient to draw clinical conclusions.

5.11 Hiccup (Singultus) Suppression

The secoiridoid bitter compounds amarogentin and gentiopicroside stimulate TAS2Rs in the oropharynx and gastrointestinal tract, triggering vagally mediated reflex activation of digestive secretions and motility. This afferent activation of the vagus nerve may engage the reflex arc involved in hiccup suppression. A case report published in Wiener klinische Wochenschrift (2025) described rapid suppression of post-propofol singultus following administration of gentian root bitters, proposing TAS2R-mediated vagal activation as the mechanism.

Evidence assessment: Single case report only; anecdotal, not controlled. Cannot be generalised.

6. Body Systems Associated with Gentian

• Gastrointestinal system: Primary area of use — appetite stimulation, secretagogue effect on gastric acid and bile, dyspepsia, flatulence, and gastroprotection.
• Hepatobiliary system: Cholagogue and hepatoprotective activities, traditionally and preclinically supported.
• Immune and inflammatory system: Inhibition of pro-inflammatory cytokines (TNF-α, IL-6) and upregulation of IL-10 in preclinical models.
• Cardiovascular system: Vasodilatory, anti-atherosclerotic, and antihypertensive properties demonstrated in cell and animal models.
• Central nervous system: Preliminary neurotrophic and neuroprotective effects via xanthones and secoiridoids in animal and cell models.
• Respiratory system: As part of the combination product Sinupret, mucoactive effects in sinusitis demonstrated in clinical trials.
• Integumentary system: Preliminary evidence for skin barrier and pigmentation-related effects.

7. Dosage Forms and Reported Dosages

Assessment of existing data for the EMA revision of the monograph led to the conclusion that the daily dose for comminuted herbal substance is within a range of 0.6 to 6 g. This range is supported by the British Herbal Pharmacopoeia (1976) and includes posologies cited in other references. The former maximum daily dose of 8 g comminuted herbal substance of the European Union monograph on Gentianae radix is not substantiated by existing references. Moreover, because of the extremely bitter taste, this maximum does not support favourable compliance.

Infusions, decoctions, and macerations of gentian roots and rhizomes have been used as a bitter digestive tonic in doses of 1 to 4 g/day. There are no clinical studies to substantiate this dosage recommendation.

In the open dyspepsia study cited above, patients were treated with a dry hydro-ethanolic extract (5:1) of gentian root at a dose of 240 mg two or three times a day (mean daily dose of 576 mg of extract, equivalent to 2.9 g of dried root).

Regarding specific preparation dosages referenced in sources:

• Comminuted herbal substance (tea/infusion): Half a teaspoon (approximately 1 gram) of dried gentian root per 150 mL of boiling water, steeped 5–10 minutes.
• Daily dose range (EMA assessment): 0.6–6 g of comminuted herbal substance per day.
• Dry extract in clinical open study: 240 mg (dry extract 5:1) two to three times daily.
• General traditional tonic range: 1–4 g/day as infusion, decoction, or maceration.
• Liquid extract supplements (as reported on product labels): The recommended amounts listed on gentian root supplements vary, including 0.5–1.5 mL for liquid extracts, 500–900 mg for pills, and 1–2 teaspoons for tea.

Gentian root medicines should only be used in adults. If symptoms last longer than 2 weeks or worsen while taking the medicine, a doctor or healthcare practitioner should be consulted.

8. Safety Considerations and Interactions

General Tolerability

At the time of the HMPC assessment, no side effects had been reported with these medicines. Gentian has a long history of use for digestive support with minimally reported adverse effects. The extract may cause headache, nausea, and vomiting. Side effects might include skin reactions and stomach upset.

Genotoxicity Concern

Mutagenicity has been demonstrated for methanolic extracts in Salmonella assays. The EMA assessment noted this finding and indicated that additional in vitro genotoxicity testing in mammalian cells was warranted before the concern could be resolved. This is an unresolved regulatory question for some preparations, particularly those with high xanthone content.

Gastric Acid-Related Contraindications

Gentian is contraindicated in gastric or duodenal ulcers, as gentian can stimulate gastric acid secretion and pepsin release, aggravating ulcerative conditions. It is also contraindicated in hyperacidity, gastritis, and gastro-oesophageal reflux disease (GERD).

Pregnancy and Lactation

Gentian is not recommended during pregnancy as it may have slight uterine stimulant properties. It is also not recommended during lactation. The use in pregnancy and lactation should be excluded due to insufficient data presented.

Blood Pressure Interactions

There is a theoretical risk that gentian may increase the risk of hypotension when combined with antihypertensive medication, but this has not been confirmed in clinical trials. Gentian is contraindicated in hypertension according to some sources. There is a concern that using gentian might make low blood pressure worse or interfere with drug treatment to increase blood pressure.

Veratrum Contamination Risk

The highly toxic white hellebore (Veratrum album) can be mistaken for gentian and has caused accidental poisoning when used in homemade preparations. Acute veratrum alkaloid poisoning has been reported due to accidental contamination of gentian preparations by veratrum. This is a documented botanical misidentification hazard with serious toxic consequences, underscoring the importance of sourcing preparations from verified suppliers.

Cytotoxicity at High Concentrations (In Vitro)

Yellow gentian (Gentiana lutea L.) displays multiple biological effects, ranging from beneficial to toxic. An in vitro study aimed to evaluate its potential concentration- and time-dependent cytotoxic and genotoxic effects by exposing human peripheral blood mononuclear cells to 0.5, 1, and 2 mg/mL of yellow gentian root extract (YGRE) to determine effects on oxidative stress parameters, DNA damage, and cell viability. This indicates a dose-dependent toxicity profile that supports caution at high doses, though such concentrations are far above typical oral intake from traditional preparations.

Hypersensitivity

Hypersensitivity to the active substance is a contraindication. Some individuals may also be hypersensitive to gentian root and develop adverse reactions.

Drug Interactions

Gentian might lower blood pressure; taking gentian along with medications that lower blood pressure might cause blood pressure to go too low. No well-documented pharmacokinetic drug–herb interactions (e.g., CYP enzyme interactions) have been confirmed in published clinical studies as of the available literature.

Conservation Status

To date, G. lutea is an imperiled species in most European countries due to the uncontrolled harvesting of roots to extract bitter glucosides; for this reason, it is under protection. This has implications for the sustainability and traceability of commercial supply chains.

9. Overall Evidence Summary

Gentian roots are a high source of bitter molecules such as amarogentin and gentiopicroside, known for their medicinal properties since ancient times. Gentian is a pleiotropic plant able to exert antioxidant, antimicrobial, anti-inflammatory, anti-atherosclerotic, antihypertensive, antiobesogenic, hepatoprotective, radioprotective, and antidepressant properties.

Studies show promise for gentian as a supportive, bitter remedy and call for further investigation into human clinical trials. The vast majority of pharmacological findings beyond the digestive domain remain in the preclinical stage. A systematic review encompassing 53 publications, including predominantly in vitro and in vivo studies and a small number of human investigations, examined the pharmacological actions of gentian root, rhizome, aerial parts, and its major constituents such as gentiopicroside, amarogentin, isovitexin, loganic acid, and xanthones. The digestive indication rests on a plausible mechanistic basis (TAS2R activation), strong traditional use documentation, two small uncontrolled human studies reporting positive effects on gastric secretion and GI symptoms, Commission E and ESCOP approval, and EMA traditional-use classification — but not on large, well-controlled randomised trials specific to Gentiana lutea alone.

References

• European Medicines Agency (EMA) — Gentianae radix herbal monograph page
• EMA — Gentian root summary for the public (HMPC)
• EMA — European Union Herbal Monograph on Gentiana lutea L., radix (Revision 1)
• EMA — Assessment Report on Gentiana lutea L., radix (2018 draft)
• EMA — Community Herbal Monograph on Gentiana lutea L., radix (first version)
• PMC — Medicinal, biological and phytochemical properties of Gentiana species
• PMC — Gentianaceae Family-Derived Bioactive Compounds: Therapeutic Values and Supporting Role in Inflammation and Detoxification
• PMC — Gentian root bitters for the rapid suppression of post-propofol singultus: a case report
• Wiener klinische Wochenschrift — Gentian root bitters for the rapid suppression of post-propofol singultus (Springer)
• PMC — Screening of Antioxidant Activity of Gentian Lutea Root and Its Application in Oil-in-Water Emulsions
• PMC — Antiobesity Effects of Gentiana lutea Extract on 3T3-L1 Preadipocytes and a High-Fat Diet-Induced Mouse Model
• PMC — Yellow Gentian Root Extract Provokes Concentration- and Time-dependent Response in Peripheral Blood Mononuclear Cells
• PMC — Results of a randomised controlled study on the efficacy of saline irrigation and Sinupret syrup in acute viral rhinosinusitis in children
• PubMed — Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis
• PubMed — Placebo-controlled, randomized double-blind clinical trial with Sinupret sugar coated tablets in acute sinusitis
• ScienceDirect — Phytochemical profiling and anti-inflammatory activity of Gentiana lutea roots from Pollino National Park (2025)
• PubMed — Phytochemical profiling and anti-inflammatory activity of Gentiana lutea roots from Pollino National Park
• ScienceDirect — The healing bitterness of Gentiana lutea L., phytochemistry and biological activities: A systematic review (2022)
• Springer — Anti-apoptotic and anti-inflammatory activity of Gentiana lutea root extract
• PMC — The Hepatoprotective Properties of Gentiopicroside, Sweroside, and Swertiamarin Against Metabolic Dysfunction-Associated Steatotic Liver Disease
• PMC — Sensitive quantitative analysis of the bitter glycoside amarogentin by monoclonal antibody-based ELISA
• Karger — Phytotherapy in Functional Gastrointestinal Disorders (Digestive Diseases)
• Drugs.com — Gentian Uses, Benefits & Dosage (medically reviewed monograph)
• Wikipedia — Gentiana lutea
• Herbal Reality — Gentian (Gentiana lutea): Benefits, Safety, Uses
• Healthy Hildegard — Gentian Root Health Benefits and Uses
• Darwin Nutrition — Gentian: benefits, dosage, contraindications